At 16, Eldiara Doucette felt pain in her right arm that she struggled to describe. “It could have easily been classified with a standard teenage ‘growing pains,’ which is, unfortunately, how a lot of ...

SAN ANTONIO — July is Sarcoma Awareness Month, a time to bring attention to many deadly types of cancer. One of those is called synovial sarcoma, which typically presents itself as a painful lump ...

A new study published today in Cancer Discovery, a journal of the American Association for Cancer Research, reports findings that may change the understanding of how synovial sarcoma develops and ...

Researchers have developed a way to attack synovial sarcoma -- a rare tumor of soft tissues, such as ligaments and muscles -- using an investigational drug that triggers cell death. Researchers at ...

The Food and Drug Administration granted accelerated approval for Adaptimmune Therapeutics’ cell therapy Tecelra in treating a specific form of cancer. The drug is on track to treat patients with ...

Plasma-activated medium (PAM) shows tumor-fighting effects against the rare form of cancer known as synovial sarcoma, an Osaka Metropolitan University-led research team has found. The group irradiated ...

Cell therapies first reached patients as treatments for blood cancers. Adaptimmune Therapeutics’ work in this therapeutic modality has culminated in an FDA nod in synovial sarcoma, a regulatory ...

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma - a rare tumor of soft tissues, such as ligaments and muscles - using an ...

Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults. While it can be cured if completely removed by surgery, recurrence or metastasis, the ...

Researchers at Washington University School of Medicine in St. Louis have developed a way to attack synovial sarcoma — a rare tumor of soft tissues, such as ligaments and muscles — using an ...